AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $9.270M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 07/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.9¢ | Day High | 0.9¢ | Day Low | 0.9¢ | |||
| Daily Volume | 77155 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 0.9¢ | 27845 | 0 | 1.0¢ | 3445820 | |
Directors & Senior Management
| Mr. Alastair Raoul Clayton | Non-Executive Chairman |
| Mr. Andrew Hume | CEO, Director & MD |
| Mr. Lincoln John Moore | Non-Executive Director |
| Mr. Rowan Harland | Joint Company Secretary |
| Mr. Stephen Frank Ronaldson | Joint Company Secretary |
| Mr. Timothy John Armstrong | Non-Executive Director |
Data source: ADVFN
